To assess the expression of CYP1B1 ex vivo, we performed immunohistochemistry assays on biopsies of healthy human kidney tissue and cisplatin-treated renal cell carcinoma (RCC) (Figure 5A,B). Here, CYP1B1 is linked to renal cell carcinoma.